Anticoagulant threpy for patients with obstetric antiphospholipid syndrome.
Phase 2
Recruiting
- Conditions
- Antiphospholipid syndrome
- Registration Number
- JPRN-jRCTs041180093
- Lead Sponsor
- Sugiura Mayumi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 200
Inclusion Criteria
Two or more early miscarriage
One or more fetal death
Preterm birth <34 weeks' gestation caused by preeclampsia or placental dysfunction
Antiphospholipid antibodies continue positive for 12 weeks.
Exclusion Criteria
abnormal chromosome in either partner
uterine anomaly
bleeding disease, renal dysfunction, liver dysfunction
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ive birth rate
- Secondary Outcome Measures
Name Time Method The frequency of heparin-induced thrombocytopenia, osteoporosis, liver dysfunction